Latest period
$243.79M
YoY change
-7.5%
5Y CAGR
+18.4%
Peak year (2022)
$435.62M
Latest annual
$276.07M
Cash on Hand history chart for Erasca (ERAS) from 2019 to 2025
Latest: $276.07M
Cash on Hand growth chart for Erasca (ERAS) from 2019 to 2025
Latest: -7.5%
Cash on Hand history table for Erasca (ERAS) from 2019 to 2025
| 2025 | $276.07M | -7.5% | −$22.23M | ||
| 2024 | $298.31M | -4.5% | −$14.04M | ||
| 2023 | $312.35M | -28.3% | −$123.27M | ||
| 2022 | $435.62M | +5.1% | +$21.14M | ||
| 2021 | $414.48M | +249.2% | +$295.77M | ||
| 2020 | $118.70M | +135.7% | +$68.33M | ||
| 2019 | $50.37M | — | — |
- 2025$276.07M-7.5%
- 2024$298.31M-4.5%
- 2023$312.35M-28.3%
- 2022$435.62M+5.1%
- 2021$414.48M+249.2%
- 2020$118.70M+135.7%
- 2019$50.37M—
Cash on Hand values are taken from Erasca's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Erasca (ERAS)
According to Erasca's latest reported financial statements, the company's latest reported cash and short-term investments is $243.79M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Erasca (ERAS) cash and short-term investments totalled $276.07M – declined 7.5% year-over-year.
Over 2020–2025 (5 years), Erasca cash and short-term investments expanded at a +18.4% compound annual rate, with mixed annual results across the window.
Erasca cash and short-term investments plunged from $435.62M in 2022 to $276.07M in 2025, a 36.6% drawdown.
The record annual cash and short-term investments stands at $435.62M, reached in 2022; the historical low of $50.37M was recorded in 2019.
Erasca Cash on Hand by Year
Erasca Cash on Hand 2025: $276.07M
In 2025, Erasca reported cash and short-term investments of $276.07M, declined 7.5% below 2024.
Erasca Cash on Hand 2024: $298.31M
Erasca cash and short-term investments in 2024 was $298.31M, edged down 4.5% below 2023.
Erasca Cash on Hand 2023: $312.35M
2023's cash and short-term investments for Erasca came in at $312.35M, declined 28.3% below 2022.
Erasca Cash on Hand 2022: $435.62M
Erasca posted cash and short-term investments of $435.62M in 2022, grew 5.1% from 2021. This figure represents the highest annual value in the available history.
Erasca Cash on Hand 2021: $414.48M
Erasca cash and short-term investments in 2021 was $414.48M.
See more financial history for Erasca (ERAS).
Sector peers by Cash on Hand
Healthcare peers of Erasca (ERAS), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Erasca (ERAS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation